Traditional Chinese medicine formula for treating pulmonary interstitial fibrosis

Abstract

The invention belongs to the technical field of traditional Chinese medicines and in particular relates to a traditional Chinese medicine formula for treating pulmonary interstitial fibrosis. The traditional Chinese medicine formula is prepared from the following traditional Chinese medicine raw materials in parts by weight: 15-20 parts of cordyceps sinensis, 10-15 parts of lucid ganoderma, 10-15 parts of astragali radix, 5-10 parts of radix asteris, 3-5 parts of bulbus fritillariae cirrhosae, 3-5 parts of cinnamon, 3-5 parts of poria cocos, 3-5 parts of rhizoma polygonati, 5-8 parts of the fruit of Chinese wolfberry and 5-8 parts of liquorice. According to the conditioning effects of the traditional Chinese medicines, the autoimmune activity of lung cells is activated, the effects of controlling fibrosis and restoring respiratory functions are achieved, and the preparation method is simple, feasible and easy to implement.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicine, in particular to a traditional Chinese medicine formula for treating pulmonary interstitial fibrosis. Background technique [0002] Diffuse pulmonary interstitial fibrosis is an inflammatory disease of the pulmonary interstitium caused by a variety of reasons. The lesions mainly involve the pulmonary interstitium, but can also involve alveolar epithelial cells and pulmonary vessels. Some causes are clear, some are not. Definite causes include inhalation of inorganic dust such as asbestos and coal; organic dust such as mildew dust and cotton dust; gases such as soot and sulfur dioxide; infection by viruses, bacteria, fungi and parasites; drug effects and radiation damage. This disease belongs to the category of "cough", "wheezing syndrome" and "pulmonary fistula" in traditional Chinese medicine. The onset is insidious and progressive. It manifests as progressive shortness o...

AI Technical Summary

Problems solved by technology

Many people prefer to use Western medicine to treat pulmonary fibrosis. Clinical studies in recent years have confirmed that the use of hormones and antibiotics against organ fibrosis can only play an anti-inflammatory role, but cannot inhibit the development of fibrosis, and long-term high-dose The use of hormones and antibiotics not only brought a variety of serious complications, but also exacerbated the deterioration of organ fibrosis